Sotera Health Company (SHC)
NASDAQ: SHC · IEX Real-Time Price · USD
12.01
+0.14 (1.18%)
At close: Mar 28, 2024, 4:00 PM
12.42
+0.41 (3.41%)
After-hours: Mar 28, 2024, 6:45 PM EDT
Sotera Health Company Market Cap
Sotera Health Company has a market cap or net worth of $3.40 billion as of March 28, 2024. Its market cap has decreased by -32.92% in one year.
Market Cap
3.40B
Enterprise Value
5.43B
1-Year Change
-32.92%
Ranking
Category
Stock Price
$12.01
Market Cap Chart
Since the IPO on November 20, 2020, Sotera Health Company's market cap has decreased from $6.42B to $3.40B, a decrease of -46.98%. That is a compound annual growth rate of -17.25%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Mar 27, 2024 | 3.36B | 2.95% |
Mar 26, 2024 | 3.26B | -1.87% |
Mar 25, 2024 | 3.32B | 3.98% |
Mar 22, 2024 | 3.20B | -2.08% |
Mar 21, 2024 | 3.26B | -2.04% |
Mar 20, 2024 | 3.33B | -10.14% |
Mar 19, 2024 | 3.71B | -8.51% |
Mar 18, 2024 | 4.05B | -1.31% |
Mar 15, 2024 | 4.11B | 2.40% |
Mar 14, 2024 | 4.01B | 1.72% |
Mar 13, 2024 | 3.94B | 1.24% |
Mar 12, 2024 | 3.89B | -1.64% |
Mar 11, 2024 | 3.96B | 1.23% |
Mar 8, 2024 | 3.91B | -1.07% |
Mar 7, 2024 | 3.95B | -1.76% |
Mar 6, 2024 | 4.02B | 1.64% |
Mar 5, 2024 | 3.96B | -4.04% |
Mar 4, 2024 | 4.13B | 0.21% |
Mar 1, 2024 | 4.12B | -3.00% |
Feb 29, 2024 | 4.25B | 0.37% |
Feb 28, 2024 | 4.23B | -13.75% |
Feb 27, 2024 | 4.90B | 1.72% |
Feb 26, 2024 | 4.82B | 1.49% |
Feb 23, 2024 | 4.75B | 1.27% |
Feb 22, 2024 | 4.69B | 1.22% |
View and export this data all the way back to 2020.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Alvotech | 3.54B |
Axonics | 3.51B |
Amicus Therapeutics | 3.50B |
Crinetics Pharmaceuticals | 3.46B |
Neogen | 3.40B |
Oscar Health | 3.26B |
Azenta | 3.26B |
Xenon Pharmaceuticals | 3.25B |